Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 0904-7506

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 0904-7506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

500mg Carton Label (6166c40c 4fbe 47c4 92e4 2dc5d3567a86 00)

500mg Carton Label (6166c40c 4fbe 47c4 92e4 2dc5d3567a86 00)
This is a product description for a unit dose of Ranolazine Extended-Release Tablets. Each tablet contains 500mg of Ranolazine. It is important to swallow the tablet whole and not crush, break, or chew it. The package contains 30 tablets (3x10) and is intended for prescription use only. The product insert should be referred to for dosage, administration, prescribing information, precautions, and warnings. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (88°F and 86°F). The package is not intended for children and is for institutional use. This product is manufactured by Ascend Laboratories, LLC and packaged and distributed by Major Pharmaceuticals in Indianapolis, USA.*
FDA Label Image

Ranolazine-structure (Ranolazine Structure)

Ranolazine-structure (Ranolazine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.